| Issuer | % of Class | Filed |
|---|---|---|
|
Processa Pharmaceuticals, Inc.
13D/A
Amendment 2
PCSA · 74275C403
|
13.0% |
2/23/2026
Event 2/13/2026
|
|
Processa Pharmaceuticals, Inc.
13D/A
Amendment 1
PCSA · 74275C304
|
10.9% |
10/15/2025
Event 8/5/2025
|
|
Processa Pharmaceuticals, Inc.
13D
PCSA · 74275C304
|
10.9% |
8/13/2025
Event 8/5/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.